|
|
|
201-500 employees
View all
|
|
Biotechnology
|
|
Eulerstrasse 55,Basel,CH
|
|
Celonic Group is a privately owned CDMO with two state-of-the-art sites located at Basel (headquarters), Switzerland and Heidelberg, Germany.
Providing comprehensive GMP development and manufacturing services for New Biological Entities (NBEs) and Biosimilars, worldwide, and Cell Therapy & Gene associated services worldwide.
Celonic’s services include the development of cell lines, production processes, as well as non-GMP and GMP manufacturing of biopharmaceutical drug substances and drug product.
To complement their services with cell line development, Celonic uses its proprietary CHOvolution™ cell line technology and the human cell line GEX® for your easy or difficult target.
Being part of the JRS Pharma family, Celonic is a strong believer in creating win-win value propositions for the clients, mitigating risks by mutually-beneficial business models.
Celonic is ambitious, driven by the courage to think big and the commitment to get it done.
Celonic services covered:
2 INDUSTRY LEADING CELL EXPRESSION PLATFORMS:
CHOvolution™:
- Powered by Celonic's proprietary SEFEX™ technology
- Cell line based on CHO-K1 (non-genetically modified CHO)
- Cell line adapted to serum-free EMA and FDA compliant media
- Simplified licensing model (no royalties from sales)
- High productivity (>7 g/l for mABs)
GEX®:
- Human cells for fully-human glycosylation
- Optimized for complex and sophisticated biopharmaceutical products
- Stable product quality over full run-time for R&D and/or GMP
- High productivity (up to 22g/l bioreactor volume for mAbs )
PROCESS DEVELOPMENT:
- State-of-art USP and DSP development
- Cutting-edge, in-house, and high throughput bioanalytics
- Robust and scalable
BIOMANUFACTURING CAPACITIES:
- Two facilities (Germany and Basel)
- Up to 2,000 L capacity batches in GMP and R&D setup
- In-house analytics
- Swissmedic GMP certified
- 20 years of optimizing perfusion technique with >100 GMP batches
FILL & FINISH:
- Up to 1,250 vials/batch -Semi-automatic aseptic filling of liquids
- > 300 Fill & Finish campaigns
- Labeling packaging and storage of clinical test samples
- Compliance with FDA & EMA standards
NEW BIOLOGICAL ENTITIES :
Celonic offers comprehensive approaches to enable clients to achieve commercial success, with a proven track record of developing breakthrough biologics and delivering GMP batches of ex. mABs, Growth Hormones, Fusion Proteins, and Blood Factors.
BIOSIMILARS :
Celonic offers ready-to-go Biosimilars (cell lines and cell pools—comprehensive analytics methods, comparability data, and development process) shaped on co-development and co-investment of next wave Biosimilars.
EMPATHIE - EFFICIENCY - EXCELLENCE
That's Celonic. Learn more about us.
|
Celonic Group Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
100%
|
The widely used Celonic Group email format is {first}.{last} (e.g. [email protected]) with 100% adoption across the company.
To contact Celonic Group customer service number in your country click here to find.
Konstantin Matentzoglu is the CEO of Celonic Group. To contact Konstantin Matentzoglu email at [email protected] or [email protected]. Or you may call +49.7532494098
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.